- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
February 24th, 2008
A research collaboration of Virtus Techno Innovations, a research and development company associated with Mumbai-based Khandelwal Laboratories, Reliance Life Sciences and SRL Ranbaxy, has succeeded in developing a novel nanotechnology-based Gene Repair Therapy (GRT) that can revolutionise treatments for various chronic diseases such as AIDS, cancer, diabetes etc. Apart from curing diseases, it can also help in reversing the ageing process.
Named as Mitsanika, the new GRT therapy activates dead or inactive genes in human body by using water as a medium to absorb the required minerals and metals that can rejuvenate and activate the genes.
The breakthrough was achieved through mimicking the experience of the fetus while floating in the amniotic fluid, said Dr V K Tripathi, chief executive officer of Virtus, who heads a team of 20 scientists who did the research on GRT for over 11 years.
|Related News Press|
News and information
FEI Launches Helios G4 DualBeam Series for Materials Science: The Helios G4 DualBeam Series features new capabilities to enable scientists and engineers to answer the most demanding and challenging scientific questions June 27th, 2016
Stealth nanocapsules kill Chagas parasites in mouse models June 22nd, 2016
Lifeboat Foundation launches 3 books December 16th, 2015
Hopes of improved brain implants October 1st, 2015